Literature DB >> 32472677

Prevalence of Alternative Diagnoses and Implications for Management in Idiopathic Normal Pressure Hydrocephalus Patients.

Mohamed Macki1, Abhimanyu Mahajan2, Rhonna Shatz2, Ellen L Air1, Marina Novikova3, Mohamed Fakih4, Jaafar Elmenini4, Manpreet Kaur5, Kenneth R Bouchard6, Brent A Funk7, Jason M Schwalb1.   

Abstract

BACKGROUND: Following Bayes theorem, ventriculomegaly and ataxia confer only a 30% chance of idiopathic Normal Pressure Hydrocephalus (NPH). When coupled with positive responses to best diagnostic testing (extended lumbar drainage), 70% of patients recommended for shunting will not actually have NPH. This is inadequate clinical care.
OBJECTIVE: To determine the proportion of alternative and treatable diagnoses in patients referred to a multidisciplinary NPH clinic.
METHODS: Patients without previously diagnosed NPH were queried from prospectively collected data. At least 1 neurosurgeon, cognitive neurologist, and neuropsychologist jointly formulated best treatment plans.
RESULTS: Of 328 total patients, 45% had an alternative diagnosis; 11% of all patients improved with treatment of an alternative diagnosis. Of 87 patients with treatable conditions, the highest frequency of pathologies included sleep disorders, and cervical stenosis, followed by Parkinson disease. Anti-cholinergic burden was a contributor for multiple patients. Of 142 patients undergoing lumbar puncture, 71% had positive responses and referred to surgery. Compared to NPH patients, mimickers were statistically significantly older with lower Montreal Cognitive Assessment (MoCA) score and worse gait parameters. Overall, 26% of the original patients underwent shunting. Pre-post testing revealed a statistically significant improved MoCA score and gait parameters in those patients who underwent surgery with follow-up.
CONCLUSION: Because the Multidisciplinary NPH Clinic selected only 26% for surgery (corroborating 30% in Bayes theorem), an overwhelming majority of patients with suspected NPH will harbor alternative diagnoses. Identification of contributing/confounding conditions will support the meticulous work-up necessary to appropriately manage patients without NPH while optimizing clinical responses to shunting in correctly diagnosed patients.
Copyright © 2020 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Ataxia; Gait; Normal pressure hydrocephalus; Shunt; Ventriculomegaly

Mesh:

Year:  2020        PMID: 32472677     DOI: 10.1093/neuros/nyaa199

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Intraventricular infusion test accuracy in predicting short- and long-term outcome of iNPH patients: a 10-year update of a three-decade experience at a single institution.

Authors:  Gianluca Trevisi; Francesco Signorelli; Chiara de Waure; Vito Stifano; Cosimo Sturdà; Alessandro Rapisarda; Angelo Pompucci; Annunziato Mangiola; Carmelo Anile
Journal:  Neurosurg Rev       Date:  2021-02-15       Impact factor: 3.042

Review 2.  Focused ultrasound: growth potential and future directions in neurosurgery.

Authors:  Michael Zhang; Adrian Rodrigues; Quan Zhou; Gordon Li
Journal:  J Neurooncol       Date:  2021-08-19       Impact factor: 4.130

3.  Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous.

Authors:  Maria Vittoria Mattoli; Giorgio Treglia; Maria Lucia Calcagni; Annunziato Mangiola; Carmelo Anile; Gianluca Trevisi
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

Review 4.  Diagnosis and treatment for normal pressure hydrocephalus: From biomarkers identification to outcome improvement with combination therapy.

Authors:  Pao-Hui Tseng; Li-Kung Wu; Yi-Cheng Wang; Tsung-Jung Ho; Shinn-Zong Lin; Sheng-Tzung Tsai
Journal:  Tzu Chi Med J       Date:  2021-04-19

5.  Shunt Surgery Efficacy Is Correlated With Baseline Cerebrum Perfusion in Idiopathic Normal Pressure Hydrocephalus: A 3D Pulsed Arterial-Spin Labeling Study.

Authors:  Wenjun Huang; Xuhao Fang; Shihong Li; Renling Mao; Chuntao Ye; Wei Liu; Guangwu Lin
Journal:  Front Aging Neurosci       Date:  2022-02-23       Impact factor: 5.750

6.  CSF tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test?

Authors:  Alessandra Griffa; Giulia Bommarito; Frédéric Assal; Maria Giulia Preti; Rachel Goldstein; Stéphane Armand; François R Herrmann; Dimitri Van De Ville; Gilles Allali
Journal:  J Neurol       Date:  2022-05-22       Impact factor: 6.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.